Cases & Deals

NGM establishes global patent portfolio related to novel protein therapies

Clients NGM Biopharmaceuticals, Inc.

Jones Day represents NGM Biopharmaceuticals, Inc. in the establishment of a global patent portfolio related to novel protein therapies for the treatment of diabetes and other metabolic disorders.

We use cookies to deliver our online services. Details of the cookies and other tracking technologies we use and instructions on how to disable them are set out in our Cookies Policy. By using this website you consent to our use of cookies.